EXCLUSIVE: WADA Yet To Decide On Appealing Iga Swiatek’s Doping Verdict
Last updated: 17/01/2025 17:39
The World Anti-Doping Agency (WADA) has confirmed to Ubitennis that they are still conducting a review into the doping case of Iga Swiatek.
Last year the five-time Grand Slam champion failed an anti-doping test after testing positive for the heart medication trimetazidine (TMZ). She was provisionally suspended for 22 days between September and October before overturning the penalty by providing evidence that the cause of her failed test was a contaminated jet lag medication she was taking.
An independent hearing later concluded that the tennis star bore “no significant fault or negligence” and did not intentionally take trimetazidine. She was later issued with a one-month suspension (including the 22 days she was provisionally suspended) with her level of fault deemed to be at the ‘lowest end of the range.’ Furthermore, the ITIA issues less severe penalties in cases involving contaminated medication compared to supplements because it is viewed to have a lower degree of risk of contamination as it is processed under EU regulation.
Following the ITIA’s decision, Poland’s National Anti-Doping Agency confirmed at the end of December that they have no plans to appeal the decision after conducting a ‘a comprehensive examination and verification of the full legal file’ concerning Swiatek. It was then confirmed that WADA has until January 21st to submit an appeal to the Court of Arbitration for Sport (CAS) if they wish to.
Now just four days before this deadline, a spokesperson for WADA has told Ubitennis that they are still ‘reviewing’ the matter after being asked if they have decided about filing an appeal. There was no mention as to when they will make a final decision.
“WADA has no comment to make about the specifics of the Swiatek case as it remains under review,” WADA said via email.
WADA is currently caught up in another tennis case concerning Jannik Sinner who failed two drugs tests in 2024 before getting cleared of wrongdoing. The ITIA found the world No.1 bore no fault in his positive tests. It was accepted that Sinner had clostebol in his system after his former physio, Giacomo Naldi, used a spray on his hand for a cut that contained the banned substance and unintentionally transferred it to him.
However, that verdict is being contested by the World Anti-Doping Agency which has filed an appeal to the Court of Arbitration for Sport (CAS) arguing that the tennis star has a degree of responsibility as he employs those in charge of making sure he complies with anti-doping rules. The hearing will take place in April.
Swiatek is currently playing at the Australian Open where she will play Emma Raducanu in the third round on Saturday. Shortly before the start of her 2025 season, the Pole told reporters that she saw no point in an appeal being filed against her.
“I gave every possible evidence and there is not much, honestly, more to do,” she said.
“There is no point to do an appeal in our opinion.
“But, you know, I guess overall, this whole process was pretty abstract sometimes and hard to understand from a point of view where you don’t think about the law and everything.
“But honestly, this is about the law and the wording and this kind of stuff. So I’m not expecting an appeal, but I have kind of no influence on what’s going to happen.
“But I can say from the processes that I went through and how they treated me from the beginning, that it seemed fair for me.”
Swiatek has a chance to reclaim her No.1 ranking whilst playing in Melbourne Park depending on her results and the performance of rival Aryna Sabalenka, who must reach at least the semi-final stage to have a chance of keeping her position.
https://www.ubitennis.net/2025/01/exclu ... g-verdict/